Emerging frontiers in nanomedicine targeted therapy for prostate cancer
Prostate cancer is a prevalent cancer in men, often treated with chemotherapy. However, it tumor cells are clinically grows slowly and is heterogeneous, leading to treatment resistance and recurrence. Nanomedicines, through targeted delivery using nanocarriers, can enhance drug accumulation at the t...
Main Authors: | Tayo Alex Adekiya, Oluwanifemi Owoseni |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Cancer Treatment and Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294223001004 |
Similar Items
-
Tango of dual nanoparticles: Interplays between exosomes and nanomedicine
by: Yabin Wang, et al.
Published: (2022-05-01) -
Editorial: Advances and Challenges in Nanomedicine
by: Susan Hua, et al.
Published: (2018-11-01) -
Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy
by: Xiaoqiu Xu, et al.
Published: (2022-05-01) -
Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials
by: Manman Xu, et al.
Published: (2023-06-01) -
Therapeutic efficacy of nanomedicines for prostate cancer: An update
by: Vinoth-Kumar Lakshmanan
Published: (2016-01-01)